You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

July 27, 2015

Protecting Unregistered IP with Unfair Competition Laws in Vietnam

Managing Intellectual Property

In early 2015, a European pharmaceutical company that markets a globally well-known pain relief drug discovered a drug with the same active ingredient and a similar name circulating on the Vietnamese market. In what the European company believed was a clear instance of “palming off,” the drug’s packaging also used colors and design elements similar to the packaging of the well-known drug. However, pursuing a trademark infringement charge was a dead end, as the Vietnamese drug’s name had already been successfully registered as a trademark.

Additionally, though it is possible to register trade indications (such as packaging designs or labels) as trademarks or industrial designs in Vietnam, affording the holder strong protection, the European company had not done so. Instead, the company resorted to Vietnam’s unfair competition laws to protect its trade indications.

Unfair Competition in Vietnam

In Vietnam, the concept of unfair competition in the IP field conforms largely to the regulations under Article 10 bis of the Paris Convention. Provisions on unfair competition in IP are found in both the Competition Law and the IP Law, though only the Competition Law provides a definition, which refers to acts that run contrary to good conscience in business practice. The Competition Law also mentions some typical acts of unfair competition, including the use of misleading trade indications, but shifts the responsibility for providing further details to the IP Law of 2005, which prohibits any use of trade indications with the purpose of causing economic injury to another business through confusion in the course of trade.

Under the unfair competition laws, a holder of unregistered trade indications can enforce its rights through civil litigation before the court, administrative action conducted by administrative enforcement bodies, or competition proceedings carried out by the Vietnam Competition Authority under the Ministry of Industry and Trade. While this may appear to be a wide range of available legal actions, in practice, most holders rely on the administrative enforcement bodies (usually the Ministry of Science and Technology (MOST) Inspectorate).

Proving Unfair Competition

To successfully argue unfair competition, a holder must conclusively prove that:

  1. it is the legitimate owner of the unregistered subject matter (packaging, labels, slogans, etc.);
  2. the subject matter has become a trade indication of the holder; and
  3. he use of the subject matter by third parties could confuse the buying public as to the origins of the products in question.

In practice, to prove the two first conditions, the competent authorities often require the IPR holder to establish the wide use of the subject matter prior to the market entry of the offender’s products in Vietnam.

Due to the lack of IP registration, the enforcement bodies are often reluctant to resolve cases independently. In most cases, they seek an expert opinion from the National Office of Intellectual Property (NOIP) on the possibility of unfair competition arising from the use of the trade indications in question. Therefore, an expert opinion, though nonbinding, usually tips the balance in unfair competition cases.

In the pain-relief-drug case cited above, the rights holder selected the MOST Inspectorate, an agency with significant experience in similar cases, as the enforcement body. The company was then able to successfully establish and provide evidence that its packaging was widely used and well-known, leading the Inspectorate to render a final ruling in favor of the holder without first asking for the NOIP’s opinion. This marks a significant improvement in the authority’s determination to resolve unfair competition cases. The case was also remarkable as it lasted just over three months, which is quite expedient for unfair competition cases in Vietnam. At the conclusion of the case, more than 100,000 infringing goods and 400 kg of aluminum foil imprinted with the infringing trade dress were ordered to be destroyed—a major victory for the European company. If this case had been handled by a different agency, the results could have been much different.

Recommendations

We have drawn from our practice the following recommendations for IPR holders to ensure success in cases of unfair competition related to the use of misleading trade indications:

  • Register the trade indication, if applicable, as soon as possible. The holder can register the entire packaging of its products as a trademark and/or industrial design (in some cases). With the registrations, the holder will stand a higher chance of successfully protecting the packaging.
  • Try to establish the goodwill of the unregistered trade indication with documentation evidencing the goodwill, such as advertising materials, goods-related sales, or charity activities.
  • Choose an agency with expertise and experience, such as the MOST Inspectorate, to handle the case. The court should be a last resort, only when there is a claim for damages.

RELATED INSIGHTS​ 

June 24, 2026
Patent enablement requirements are provided under Article 102 of Vietnam’s Law on Intellectual Property (IP Law). In particular, a patent specification must “fully and clearly disclose the nature of the invention to such an extent that, based on the specification, a person having ordinary skill in the relevant art can implement the invention.” In pharmaceutical and biotechnology patents, this requirement is more complicated and subject to more rigorous assessment. The Patent Examination Guidelines (Guidelines) of the Intellectual Property Office of Vietnam (IP Office) were amended in March 2026 to introduce Annexes III and IV for the pharmaceutical and biotechnology sectors, in which Annex III provides detailed guidelines on the assessment of specification requirements. These amendments were made under a project for strengthening capacity in industrial property examination between the Japan International Cooperation Agency (JICA) and the IP Office. Annex III provides detailed instructions on how examiners assess enablement in a pharmaceutical or biotechnology application, and offers examples of acceptable and unacceptable descriptions with regard to the enablement aspect. Enablement Requirements in Pharma and Biotech Patents Article 12.7 of Circular 10/2026/TT-BKHCN (Circular 10) adds to the requirements of Article 102 of the IP Law that the description must demonstrate the novelty, inventive step, and industrial applicability of the technical solution. For pharmaceutical composition subject matters, Article 12.9 of Circular 10 sets out that the description must present the results of clinical trials and/or the pharmacological effects of the claimed pharmaceutical composition, and must include at least the following information: Substance/mixture used. Testing method (system) employed. Information on the test results. Correlation between the pharmacological effects obtained from the tests and the application of the pharmaceutical product in the prevention, diagnosis, and treatment of diseases. The Guidelines note that pharmacological study results should be presented in a quantified manner, and pharmacological
June 16, 2026
Since the implementation of the Trademark Law 2019 on April 1, 2023, Myanmar has operated under a modern first-to-file trademark system that brings its registration framework closer to international practice. As the new regime continues to develop in practice, applicants are increasingly required to navigate formal examination requirements, substantive objections, and procedural deadlines with greater precision. This article provides a high-level review of the trademark examination process in Myanmar, focusing on the principal stages from initial review to approval, the types of objections commonly raised by the Intellectual Property Department (IPD), and the key considerations for responding effectively. A clear understanding of these issues is essential for applicants seeking to secure registration efficiently and to mitigate avoidable delays or refusals. Examination Process: Key Stages Trademark applications filed with the IPD undergo two stages of review. Formality Examination The IPD first verifies compliance with procedural requirements, including: Correct Nice Classification Clear mark representation Accurate applicant details Clearly defined goods or services Representative details, if the application is filed by a representative Other formality requirements cover translation and transliteration of any non-English or non-Myanmar elements in the mark, color claim details, applicable disclaimers, and payment of official fees. Deficiencies result in an office action requiring correction within 30 days, which may be extended upon request. Registrability Examination The IPD also assesses registrability. A mark may be refused if it: Lacks distinctiveness Is descriptive or generic Misleads the public or violates public order/morality Contains prohibited state symbols Only compliant applications proceed to publication. Responding to Office Actions Applicants must respond within 30 days of notification from the IPD. Depending on the nature of the objection, strategies may include submitting legal arguments for distinctiveness, providing evidence of acquired distinctiveness, filing appropriate disclaimers, clarifying descriptions such as color claims, or amending the listed goods
June 15, 2026
The surge in AI development has led to a desperate demand for large, high-quality training data. However, real-world data can be expensive to collect, difficult to access, and often subject to strict privacy and regulatory constraints. Synthetic data, which consists of artificially generated records that replicate the statistical properties of real-world data without reproducing specific individuals’ information, provides an appealing solution by generating artificial datasets at scale without relying on identifiable personal information. It combines speed, cost efficiency, and regulatory compliance, making it a sensible alternative for organizations seeking to reduce risks while maintaining data utility. When properly anonymized, synthetic datasets may fall outside the scope of laws such as the EU’s General Data Protection Regulation (GDPR) or Thailand’s Personal Data Protection Act (PDPA), reducing compliance burdens while still supporting high-quality model training. However, relying on synthetic data without rigorous legal due diligence could be a strategic mistake. It replaces one set of known risks (scraping, direct privacy liability) with a new set of complex liabilities. The narrative that synthetic data is a “silver bullet” for privacy and IP compliance is dangerous and could be misleading. While synthetic data addresses data scarcity, it also introduces new legal uncertainties. Legal counsel should anticipate downstream risks arising from compromised data sources. Models trained on unlawfully obtained data may need to be decommissioned, even if their outputs appear lawful. What is synthetic data? Synthetic data refers to artificially generated information created using AI techniques such as deep learning and generative models. Instead of copying real records, it reproduces the statistical patterns and relationships found in the original dataset. Synthetic data generally falls into three categories: Fully synthetic data – Entirely new data points generated from learned patterns. The model studies the structure of the original data and produces records that resemble real-world
June 10, 2026
In March 2026, the Intellectual Property Office of Vietnam (IP Office) issued a decision refusing a trademark application after considering an opposition based primarily on copyright grounds. The outcome is noteworthy because the foreign brand owner had neither trademark registrations nor applications in Vietnam at the time the opposition was filed, and the IP Office has historically applied a stringent approach to oppositions relying on copyright. The Opposition Maurten is a well-known Swedish sports nutrition brand recognized globally for its innovative hydrogel technology, which is designed to help endurance athletes fuel more effectively without gastrointestinal discomfort. The brand’s distinctive logo is characterized by clean lines and a bold black-and-white color scheme, and has long been associated with the company’s performance products. The brand’s logo is displayed above. An identical mark was filed for registration by a Vietnamese trademark squatter. In 2023, a Vietnamese individual filed an application for registration of an identical mark (Application No. 4-2023-38668), a practice commonly observed in Vietnam as trademark squatting. The brand owner engaged Tilleke & Gibbins to assist with strategy and filing an opposition to the mark. At the time, Maurten had no trademark rights or meaningful use in Vietnam, and global marketing data showed only modest figures without any local presence. Thus, to convince the IP Office to refuse the squatter’s application, instead of relying on trademark rights or use evidence, the opposition strategy centered on the copyright protection of the logo itself, as copyright arises automatically in Vietnam upon creation of the work and does not require registration. (It is worth noting, however, that the IP Office has traditionally been cautious in accepting copyright as a basis for refusing trademark applications.) On September 24, 2024, an opposition was filed on three main grounds: confusing similarity, copyright infringement of the artistic work,